FDA this week approved its first genotyping test for patients with hepatitis C virus (HCV), Abbott’s RealTime HCV Genotype II. The test can differentiate genotypes ...

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health Assays for genomic analysis of plasma cell-free DNA (cfDNA) ...

Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer We performed a retrospective ...

(RTTNews) - Cue Health (HLTH) will develop an Omicron-Genotyping COVID-19 test to be used in professional point-of-care settings as part of the company's ongoing work with the U.S. Department of ...

Mass General Brigham researchers developed and evaluated a rapid genotyping test for patients who present with a central nervous system lesion, eliminating need for an invasive surgical biopsy in ...

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. ("DiamiR"), a developer of innovative blood-based diagnostic tests for brain health and ...

For an initial pilot phase of this project, we used innovation funding from Tayside health board to request genotype testing for the indicated population (600-800 patients per year) managed by the ...

Aptorum Group shares skyrocketed as New York State Department of Health approved a genotyping test from DiamiR Biosciences, which is merging with Aptorum. The stock more than doubled to $3.37 and is ...

Aptorum (APM) stock underwent a massive rally on Thursday after the biopharmaceutical company announced Clinical Laboratory Evaluation Program (CLEP) Test Approval for blood testing company DiamiR ...

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and ...